Authors



Linda Stein Gold, MD

Latest:

Understanding Dosing Requirements with Isotretinoin

Experts in dermatology review the dosing and meal requirements need with isotretinoin administration, highlighting the impact and benefit of the novel lidose and micronized formulations.



Tom Ferry, MBA

Latest:

How Physicians Can Provide Better Care for Patients with Chronic Conditions

Technology and care navigators are key to managing this growing population


Lily Guo

Latest:

Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic Dermatitis

Recent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.


Bob Peelman

Latest:

Do You Have the Right Financial Adviser?

Experts detail 5 tips to ask a financial advisor so they can best serve your interests.



James Q. Del Rosso, DO

Latest:

Advances in the Management of Adult Plaque Psoriasis

In this upcoming video series, James Q. Del Rosso, DO, will lead a conversation focusing on the practical considerations and clinical management of patients suffering from plaque psoriasis by reviewing the current treatment landscape and discussing individual patient cases.


Marian Freedman

Latest:

Does diet really play a role in acne?

For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.



Peter Baek

Latest:

An Overview of Argyria

Argyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.



Jeremy D. Sherer, JD

Latest:

Telehealth in 2023: What Physicians Need to Know

Answers to some common questions about providing telehealth services in 2023.


Joel M. Gelfand, MD, MSCE, FAAD

Latest:

Addressing Patients' Concerns With Biosimilars

Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.


Heidi Anne Duerr, MPH

Latest:

Annual Meeting Session Highlights Clinical Pearls in Medical Dermatology

A key session at the annual meeting will share practical advice and tools to better support you and your patients.




Benjamin Lockshin, MD, FAAD

Latest:

Future Directions in the Treatment of Atopic Dermatitis

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, talk about how clinical approaches and understanding of risk/benefit profiles are evolving in light of the emerging long-term data.


Hilary Baldwin, MD

Latest:

Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

In the final part of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.


Courtney Marabella

Latest:

Topical Remetinostat Effective, Tolerable in Basal Cell Carcinoma

The topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.


Adam Braunscheidel, CFP

Latest:

Rule 1 for Investing During Volatile Markets: Stick to Your Plan

In this month's financial planning column, the OJM group talks about volatile markets and how to navigate investing in uncertain times.


Elizabeth Swanson, MD

Latest:

Take-Home Points

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.


Giuliana Grossi

Latest:

Pregnancy outcomes vary in women with psoriatic arthritis

The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.



Gina Mauro

Latest:

FDA Grants Orphan Drug Status to ITIL-168 for Melanoma

The FDA has granted an Orphan Drug designation to the investigational tumor-infiltrating lymphocyte therapy ITIL-168 for the treatment of patients with stage IIB to IV melanoma.



Carrie Nagorka, Senior Editor

Latest:

FDA Panel Questions Isotretinoin iPLEDGE REMS

The 2 votes came at the end of the second day of a joint meeting of the FDA's Drug Safety and Risk Management Advisory Committee and Dermatologic and Ophthalmic Drugs Advisory Committee.


Brandon May

Latest:

Acne Flares May be Worsened by Climate Change

Changes in the cutaneous microbiome triggered by warmer temperatures and increased UV radiation may stimulate C. acnes growth.


Sherry G. Cohen, NP-C

Latest:

Treating Seborrheic Dermatitis

A look at the common condition and how to treat it.


© 2023 MJH Life Sciences

All rights reserved.